NCT00197288View on ClinicalTrials.gov

Study Comparing the Immune Response of Fluarix and Fluzone Influenza Vaccines

PHASE3CompletedINTERVENTIONAL
Enrollment

1,847

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

May 31, 2006

Study Completion Date

June 30, 2006

Conditions
Influenza
Interventions
BIOLOGICAL

Influenza

Trial Locations (15)

12601

GSK Investigational Site, Poughkeepsie

14209

GSK Investigational Site, Buffalo

15106

GSK Investigational Site, Carnegie

15236

GSK Investigational Site, Pittsburgh

16506

GSK Investigational Site, Erie

19107

GSK Investigational Site, Philadelphia

21201

GSK Investigational Site, Baltimore

33761

GSK Investigational Site, Clearwater

45229

GSK Investigational Site, Cincinnati

47714

GSK Investigational Site, Evansville

54449

GSK Investigational Site, Marshfield

63110

GSK Investigational Site, St Louis

77030

GSK Investigational Site, Houston

77450

GSK Investigational Site, Katy

02886

GSK Investigational Site, Warwick

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY